{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:16:37Z","timestamp":1784967397135,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation (NRF) of Korea","doi-asserted-by":"crossref","award":["RS-2021-NR059245"],"award-info":[{"award-number":["RS-2021-NR059245"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea","award":["RS-2024-00332875"],"award-info":[{"award-number":["RS-2024-00332875"]}]},{"name":"The Ministry of Health & Welfare, Republic of Korea","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}]},{"name":"The Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea","award":["RS-2024-00334574"],"award-info":[{"award-number":["RS-2024-00334574"]}]},{"DOI":"10.13039\/501100006107","name":"Gil Medical Center, Gachon University","doi-asserted-by":"publisher","award":["FRD2025-01"],"award-info":[{"award-number":["FRD2025-01"]}],"id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education","award":["RS-2021-NR060117"],"award-info":[{"award-number":["RS-2021-NR060117"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-01994-w","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:25:35Z","timestamp":1772241935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of circulating proteasome activity with Alzheimer\u2019s pathology and cognitive functions in APOE \u03b54 carriers"],"prefix":"10.1186","volume":"18","author":[{"given":"Bon Gook","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Eun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daegyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myeong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaelim","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"7113","key":"1994_CR1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"DC Rubinsztein","year":"2006","unstructured":"Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443(7113):780\u20136.","journal-title":"Nature"},{"issue":"3","key":"1994_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015;47(3):e147.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1994_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(94)91757-4","volume":"639","author":"T Kudo","year":"1994","unstructured":"Kudo T, et al. Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res. 1994;639(1):1\u20137.","journal-title":"Brain Res"},{"issue":"1","key":"1994_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem. 2000;75(1):436\u20139.","journal-title":"J Neurochem"},{"key":"1994_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009;78:477\u2013513.","journal-title":"Annu Rev Biochem"},{"issue":"18","key":"1994_CR6","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1073\/pnas.1305782110","volume":"110","author":"P Sledz","year":"2013","unstructured":"Sledz P, et al. Structure of the 26S proteasome with ATP-gammaS bound provides insights into the mechanism of nucleotide-dependent substrate translocation. Proc Natl Acad Sci U S A. 2013;110(18):7264\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1994_CR7","doi-asserted-by":"publisher","first-page":"15765","DOI":"10.1038\/s41598-020-71550-5","volume":"10","author":"J Abi Habib","year":"2020","unstructured":"Abi Habib J, et al. Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins. Sci Rep. 2020;10(1):15765.","journal-title":"Sci Rep"},{"issue":"7","key":"1994_CR8","doi-asserted-by":"publisher","first-page":"112701","DOI":"10.1016\/j.celrep.2023.112701","volume":"42","author":"HW Choi","year":"2023","unstructured":"Choi HW, et al. ECPAS\/Ecm29-mediated 26S proteasome disassembly is an adaptive response to glucose starvation. Cell Rep. 2023;42(7):112701.","journal-title":"Cell Rep"},{"issue":"22","key":"1994_CR9","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.2174\/092986709788803187","volume":"16","author":"AR Wyatt","year":"2009","unstructured":"Wyatt AR, et al. Therapeutic targets in extracellular protein deposition diseases. Curr Med Chem. 2009;16(22):2855\u201366.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1994_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-200728","volume":"78","author":"Y Yun","year":"2020","unstructured":"Yun Y, et al. Proteasome Activity in the Plasma as a Novel Biomarker in Mild Cognitive Impairment with Chronic Tinnitus. J Alzheimers Dis. 2020;78(1):195\u2013205.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1994_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1088\u201393.","journal-title":"Nat Genet"},{"issue":"12","key":"1994_CR12","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"1994_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1994_CR14","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"1994_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1994_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/01.wnl.0000400650.92875.cf","volume":"77","author":"G McKhann","year":"2011","unstructured":"McKhann G, et al. Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 2011;77(4):333\u2013333.","journal-title":"Neurology"},{"issue":"23","key":"1994_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","volume":"364","author":"CR Petersen","year":"2011","unstructured":"Petersen CR. Mild Cognitive Impairment. N Engl J Med. 2011;364(23):2227\u201334.","journal-title":"N Engl J Med"},{"key":"1994_CR18","doi-asserted-by":"crossref","unstructured":"Ahn HJ, Chin J, Park A, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010;25(7):1071\u20136.","DOI":"10.3346\/jkms.2010.25.7.1071"},{"issue":"1","key":"1994_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12779\/dnd.2023.22.1.1","volume":"22","author":"HJ Ryu","year":"2023","unstructured":"Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment. Dement Neurocogn Disord. 2023;22(1):1\u201315.","journal-title":"Dement Neurocogn Disord"},{"issue":"3","key":"1994_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31(3):968\u201380.","journal-title":"NeuroImage"},{"issue":"10","key":"1994_CR21","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","volume":"59","author":"MA Walji","year":"2016","unstructured":"Walji MA, et al. Discovery of 6-(Fluoro-18 F)-3-(1 H-pyrrolo [2, 3-c] pyridin-1-yl) isoquinolin-5-amine ([18F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs). J Med Chem. 2016;59(10):4778\u201389.","journal-title":"J Med Chem"},{"key":"1994_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve DN, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. NeuroImage. 2014;92:225\u201336.","journal-title":"NeuroImage"},{"key":"1994_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, et al. Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging. NeuroImage. 2016;132:334\u201343.","journal-title":"NeuroImage"},{"issue":"10","key":"1994_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2967\/jnumed.114.142109","volume":"55","author":"L Thurfjell","year":"2014","unstructured":"Thurfjell L, et al. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. J Nucl Med. 2014;55(10):1623\u20138.","journal-title":"J Nucl Med"},{"key":"1994_CR25","doi-asserted-by":"crossref","unstructured":"Collij LE, Salvad\u00f3 G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [(18)F] flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021;48(7):2169\u201382.","DOI":"10.1007\/s00259-020-05174-2"},{"issue":"4","key":"1994_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1994_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, et al. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron"},{"key":"1994_CR28","doi-asserted-by":"crossref","unstructured":"Pascoal AT, et al. In vivo quantification of neurofibrillary tangles with [18F] MK-6240. Alzheimers Res Ther. 2018;10(1).","DOI":"10.1186\/s13195-018-0402-y"},{"issue":"10","key":"1994_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s12276-021-00692-x","volume":"53","author":"WH Choi","year":"2021","unstructured":"Choi WH, et al. Concept and application of circulating proteasomes. Exp Mol Med. 2021;53(10):1539\u201346.","journal-title":"Exp Mol Med"},{"issue":"4","key":"1994_CR30","doi-asserted-by":"publisher","first-page":"102748","DOI":"10.1016\/j.xpro.2023.102748","volume":"4","author":"I Byun","year":"2023","unstructured":"Byun I, et al. Purification and characterization of different proteasome species from mammalian cells. STAR Protocols. 2023;4(4):102748.","journal-title":"STAR Protocols"},{"key":"1994_CR31","doi-asserted-by":"crossref","unstructured":"Ukmar-Godec T, Ib\u00e1\u00f1ez de Opakua FP, Henneberg A, Godec F, Pan A, Cima-Omori KT, et al. Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution. Sci Adv. 2020;6(30):eaba3916.","DOI":"10.1126\/sciadv.aba3916"},{"issue":"7382","key":"1994_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG. Statistics Notes: Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219\u2013219.","journal-title":"BMJ"},{"key":"1994_CR33","doi-asserted-by":"crossref","unstructured":"Tingley D, et al. Mediation: R package for causal mediation analysis. J Stat Softw. 2014;59(5):1\u201338.","DOI":"10.18637\/jss.v059.i05"},{"issue":"10","key":"1994_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1021\/cn100067e","volume":"1","author":"X Zhao","year":"2010","unstructured":"Zhao X, Yang J. Amyloid-beta peptide is a substrate of the human 20S proteasome. ACS Chem Neurosci. 2010;1(10):655\u201360.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1994_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1471-4159.2002.01137.x","volume":"83","author":"DC David","year":"2002","unstructured":"David DC, et al. Proteasomal degradation of tau protein. J Neurochem. 2002;83(1):176\u201385.","journal-title":"J Neurochem"},{"issue":"6220","key":"1994_CR36","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"issue":"6959","key":"1994_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nature02046","volume":"425","author":"S Ghaemmaghami","year":"2003","unstructured":"Ghaemmaghami S, et al. Global analysis of protein expression in yeast. Nature. 2003;425(6959):737\u201341.","journal-title":"Nature"},{"issue":"1","key":"1994_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","volume":"85","author":"S Keck","year":"2003","unstructured":"Keck S, et al. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease. J Neurochem. 2003;85(1):115\u201322.","journal-title":"J Neurochem"},{"key":"1994_CR39","doi-asserted-by":"crossref","unstructured":"Thibaudeau AT, Anderson TR, Smith MD. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat Commun. 2018;9(1):1097.","DOI":"10.1038\/s41467-018-03509-0"},{"issue":"8","key":"1994_CR40","doi-asserted-by":"publisher","first-page":"e0182895","DOI":"10.1371\/journal.pone.0182895","volume":"12","author":"GLK Farizatto","year":"2017","unstructured":"Farizatto GLK, et al. A\u03b242-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways. PLoS ONE. 2017;12(8):e0182895.","journal-title":"PLoS ONE"},{"key":"1994_CR41","doi-asserted-by":"crossref","unstructured":"Kim J, et al. Extracellular vesicle-mediated delivery of 20S proteasomes enhances tau degradation in recipient cells. J Extracell Vesicles. 2025;14(5):e70086.","DOI":"10.1002\/jev2.70086"},{"issue":"12","key":"1994_CR42","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","volume":"80","author":"A Steward","year":"2023","unstructured":"Steward A, et al. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels. JAMA Neurol. 2023;80(12):1295.","journal-title":"JAMA Neurol"},{"issue":"12","key":"1994_CR43","doi-asserted-by":"publisher","first-page":"e1012407","DOI":"10.1371\/journal.pcbi.1012407","volume":"20","author":"RN Zuniga","year":"2024","unstructured":"Zuniga RN, et al. Quantitative and Kinetic Proteomics Reveal ApoE Isoform-dependent Proteostasis Adaptations in Mouse Brain. PLoS Comput Biol. 2024;20(12):e1012407.","journal-title":"PLoS Comput Biol"},{"key":"1994_CR44","doi-asserted-by":"crossref","unstructured":"Davidson K, Pickering MA. The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease. Front Cell Dev Biology. 2023;11:1124907.","DOI":"10.3389\/fcell.2023.1124907"},{"key":"1994_CR45","doi-asserted-by":"crossref","unstructured":"Kloske CM, Wilcock DM. The important interface between apolipoprotein E and neuroinflammation in alzheimer\u2019s disease. Front Immunol. 2020;11:754.","DOI":"10.3389\/fimmu.2020.00754"},{"issue":"3","key":"1994_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molmed.2024.10.006","volume":"31","author":"SM Ahammed","year":"2025","unstructured":"Ahammed SM, Wang X. Promoting proteostasis by cAMP\/PKA and cGMP\/PKG. Trends Mol Med. 2025;31(3):224\u201339.","journal-title":"Trends Mol Med"},{"issue":"12","key":"1994_CR47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3390\/biom11121789","volume":"11","author":"ED George","year":"2021","unstructured":"George ED, Tepe JJ. Advances in Proteasome Enhancement by Small Molecules. Biomolecules. 2021;11(12):1789.","journal-title":"Biomolecules"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01994-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:15:22Z","timestamp":1775564122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01994-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01994-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8306028\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants and their guardians (in case of dementia patients). This study was approved by the Institutional Review Board (IRB # GBIRB2018-350) and was registered at the Clinical Research Information Service of Korea (CRIS: KCT0005428).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All figures and tables included in this manuscript have been carefully reviewed. This manuscript does not contain any contents that dispose of any direct or indirect identifiers. Datasets have been fully anonymized and no identifiable personal information is presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}